Abstract: Reusable catheter products are provided for storing, transporting, and sterilizing reusable urinary catheters.

Abstract: The present invention provides, among other things, soluble derivatives of soluble polypeptides that incorporate membrane binding elements. Methods of making these soluble derivatives, and methods of using these soluble derivatives also are provided.

Abstract: The present invention provides, among other things, soluble derivatives of soluble polypeptides that incorporate membrane binding elements. Methods of making these soluble derivatives, and methods of using these soluble derivatives also are provided.

Abstract: The present invention provides, among other things, soluble derivatives of soluble polypeptides that incorporate membrane binding elements. Methods of making these soluble derivatives, and methods of using these soluble derivatives also are provided.

Abstract: The present invention provides, among other things, soluble derivatives of soluble polypeptides that incorporate membrane binding elements. Methods of making these soluble derivatives, and methods of using these soluble derivatives also are provided.

Abstract: Soluble polypeptides are provided that comprise no more than three short consensus repeats (SCR) of Complement Receptor 1, and contain SCR3. DNA molecules encoding such soluble polypeptides, as well as methods, vectors and host cells, also are provided.

Abstract: A soluble polypeptide comprising, in sequence, one to four short consensus repeats (SCR) selected from SCR 1, 2, 3 and 4 of long homologous repeat A (LHR-A) as the only structurally and functionally intact SCR domains of CR1 and including at least SCR3.

Abstract: A rotary lobe pump comprises a pump housing defining an obround pump chamber and a pair of lobe rotors in the pump chamber. The rotors are mounted on rotatable shafts which are connected by timing gears such that the rotors rotate to cause a fluid to displace through the chamber. The pump chamber is defined in the pump housing by opposed front and rear end walls which are perpendicular to the axes of the rotors and by arcuate side walls with which the rotors make sealing contact and which gradually wear out thereby reducing the tightness of the seal and thus the pumping efficiency of the rotary lobe pump. The rear end wall includes two removable end wear plates which each include a rearwardly projecting key engaged in a corresponding keyway defined in the pump housing with bolts extending from outside of the housing inwardly towards the end wear plates and engaging the keys thereof for securing the end wear plates to the housing.

Abstract: The safety barrier system prevents a person from being caught under a wheel of a vehicle and is provided with a sensing system to inform the driver of the presence of the person on the barrier during start up. The sensing system combines a first sensor (for example, a pressure sensor) with an infrared sensor, and includes a snow switch for selectively using the first sensor and/or the infrared sensor depending on the weather conditions. The barrier is mounted to the vehicle by a motor drive mechanism to lower the barrier when stopped and to raise the barrier after the vehicle has travelled a given distance. The system is particularly suitable for school buses.

Abstract: A purified fibrinolytically active degraded species of tissue-type plasminogen activator comprising a fibrinolytically intact B chain of native t-PA linked to kringle 2 as the only functionally and structurally intact domain of native t-PA A chain.

Abstract: A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to a chain of a different 2-chain protease, or to the same chain of the same protease, at least one of the chains in the hybrid protein being derived from a fibrinolytically active protease, such that the hybrid protein has a catalytic site essential for fibrinolytic activity which is optionally blocked by a removable blocking group.

Abstract: A purified fibrinolytically active degraded species of tissue-type plasminogen activator comprising a fibrinolytically intact B chain of native t-PA linked to kringle 2 as the only functionally and structurally intact domain of native t-PA A chain.

Abstract: A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to a chain of a different 2-chain protease, or to the same chain of the same protease, at least one of the chains in the hybrid protein being derived from a fibrinolytically active protease, such that the hybrid protein has a catalytic site essential for fibrinolytic activity which is optionally blocked by a removable blocking group.

Abstract: A hybrid protein which comprises plasmin A-chain linked to urokinase B-chain, the catalytic site of which is blocked by a removable blocking group.

Abstract: A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to a chain of a different 2-chain protease, or to the same chain of the same protease, at least one of the chains in the hybrid protein being derived from a fibrinolytically active protease, such that the hybrid protein has a catalytic site essential for fibrinolytic activity which is optionally blocked by a removable blocking group.